Experts, advocates urge continued funding for research into HIV, TB vaccines

"[P]articipants at a symposium held last week by the U.K. Consortium on AIDS and International Development warned that [progress on HIV and tuberculosis (TB) vaccines] could be jeopardized by the recent downturn in global health funding," BMJ reports. The journal summarizes comments made at the meeting by researchers and advocacy group representatives, who stressed that successful vaccines for HIV and TB would save millions in existing research investments and long-term treatment costs (Moszynski, 5/22).